Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation

被引:18
|
作者
Usoh, Chinenye O.
Sherazi, Saadia
Szepietowska, Barbara
Kutyifa, Valentina
McNitt, Scott
Papernov, Anna
Wang, Meng
Alexis, Jeffrey D.
机构
[1] Wake Forest Univ, Sch Med, Div Endocrinol & Metab, Winston Salem, NC 27109 USA
[2] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Cardiol Div, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Div Cardiol, Rochester, NY USA
来源
ANNALS OF THORACIC SURGERY | 2018年 / 106卷 / 02期
关键词
ADVANCED HEART-FAILURE; RISK-FACTORS; STROKE; IMPACT; IMPROVEMENT; PREVALENCE; PLACEMENT;
D O I
10.1016/j.athoracsur.2018.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite previous studies, the mortality risk of patients with diabetes mellitus after left ventricular assist device (LVAD) implant remains unclear. In addition, the relationship between the degree of glycemic control and long-term mortality risk in LVAD patients with diabetes has not been established. Methods. Ninety-five nondiabetic patients and 96 diabetic patients from the University of Rochester Medical Center who received a HeartMate II (Thoratec, Pleasanton, CA) continuous-flow LVAD between May 2008 and June 2014 were included in this study. The primary outcome was all-cause mortality. Secondary outcomes included rates of infection, neurologic dysfunction, renal dysfunction, and rehospitalization. Kaplan-Meier survival analyses and Cox models were utilized. Results. During follow-up, 32 diabetic patients (33%) and 15 nondiabetic patients (16%) died after LVAD implantation. Cumulative probability of death was higher for diabetic patients when compared with nondiabetic patients (42% versus 21% at 3 years, p = 0.013). There were no significant differences in overall rates of infection, neurologic dysfunction, and rehospitalization between the two groups. However, after an initial secondary outcome event, diabetic patients continued to have a higher mortality rate when compared with nondiabetic patients. There was no statistically significant difference in the risk of death between diabetic patients with pre-LVAD hemoglobin A1c less than 7.0% and diabetic patients with pre-LVAD hemoglobin A1c 7.0% or greater (hazard ratio 1.71, 95% confidence interval: 0.72 to 4.08, p = 0.223). Conclusions. Diabetic patients who underwent LVAD implantation had a higher risk of death compared with nondiabetic patients. Adverse event rates did not differ between the two groups. Finally, the degree of glycemic control in diabetic patients before LVAD was not found to influence mortality. (C) 2018 by The Society of Thoracic Surgeons
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [1] Impact of Diabetes Mellitus on Mortality and In-Hospital Outcomes after Left Ventricular Assist Device Implantation
    Blumer, V.
    Ortiz, M.
    Hernandez, G.
    Chaparro, S.
    Vest, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S81 - S81
  • [2] Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation
    Vest, Amanda R.
    Mistak, Stanley M.
    Hachamovitch, Rory
    Mountis, Maria M.
    Moazami, Nader
    Young, James B.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (10) : 789 - 796
  • [3] Outcomes and Complications after Left Ventricular Assist Device Implantation
    Wasilewski, Grzegorz
    Wisniowska-Smialek, Sylwia
    Gorkiewicz-Kot, Izabela
    Milaniak, Irena
    Kaleta, Michal
    Hymczak, Hubert
    Tomsia, Paulina
    Wierzbicki, Karol
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (04) : 864 - 867
  • [4] Left ventricular assist device implantation in patients after left ventricular reconstruction
    Palmen, Meindert
    Braun, Jerry
    Beeres, Saskia L. M. A.
    Klautz, Robert J. M.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2016, 23 (06) : 979 - 981
  • [5] Outcomes of left ventricular assist device implantation in hypercoagulable patients
    Dufendach, Keith A.
    Seese, Laura
    Stearns, Blaise
    Hickey, Gavin
    Mathier, Michael
    Keebler, Mary
    Chen, Shangzhen
    Sciortino, Christopher M.
    Thoma, Floyd W.
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (09) : 2201 - 2207
  • [6] Outcomes of Patients with Right Ventricular Failure on Milrinone After Left Ventricular Assist Device Implantation
    Tsiouris, Athanasios
    Paone, Gaetano
    Brewer, Robert J.
    Nemeh, Hassan W.
    Borgi, Jamil
    Morgan, Jeffrey A.
    ASAIO JOURNAL, 2015, 61 (02) : 133 - 138
  • [7] Diabetes and outcomes after left ventricular assist device placement
    Butler, J
    Howser, R
    Portner, PM
    Pierson, RN
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (07) : 510 - 515
  • [8] Outcomes of Patients Referred for Cardiac Rehabilitation after Left Ventricular Assist Device Implantation
    Shaaban, A.
    Schultz, J.
    Leonard, J.
    John, R.
    Martin, C. M.
    Alexy, T.
    Pritzker, M.
    Thenappan, T.
    Kamdar, F.
    Shaffer, A.
    Cogswell, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S181 - S182
  • [9] Meta-Analysis Comparing Risk for Adverse Outcomes After Left Ventricular Assist Device Implantation in Patients With Versus Without Diabetes Mellitus
    Lateef, Noman
    Usman, Muhammad Shariq
    Colombo, Paolo C.
    Ahmed, Saba
    Khan, Muhammad Shahzeb
    Khan, Safi U.
    Garan, Arthur R.
    Yuzefpolskaya, Melana
    Demmer, Ryan T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (12): : 1918 - 1923
  • [10] Are Patients With Diabetes Mellitus at Increased Risk for Adverse Outcomes After Left Ventricular Assist Device Implantation? A Systematic Review and Meta-Analysis
    Khan, Muhammad S.
    Colombo, Paolo C.
    Lateef, Noman
    Usman, Muhammad S.
    Khan, Safi U.
    Garan, Arthur R.
    Yuzefpolskaya, Melana
    Demmer, Ryan T.
    CIRCULATION, 2018, 138